Pharmaceuticals, Biotechnology and Life Sciences
FDA stated it is not currently planning to hold an advisory committee meeting
Potential for Vicineum to be a best-in-class treatment with projected peak revenue of $1B-$3B globally, $400M-$900M in the US
Company to hold conference call at 8am ET
CAM…
LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) – a novel class of drug derived from the microbiome, today announces Duncan Peyton, Chief Executive Offi…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) announced today that the company has placed its Phase 1/2 (HGB-206) and Phase 3 (HGB-210) studies of LentiGlobin gene therapy for sickle cell disease (SCD) (bb1111) on a temporary sus…
Express Scripts coverage effective February 5, 2021
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for disea…
Gil Van Bokkelen to Step Down as Chairman and CEO; B.J. Lehmann Appointed Interim CEO
Board Initiating Search for Permanent Successor; Ismail Kola appointed Chairman of the Board
Company Postpones Investor Day
CLEVELAND, Ohio–(BUSINESS WIRE)–$ATHX…
Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella
Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Hen…
Rapid Antigen and PCR Testing Offered to Asymptomatic School District Employees
BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the c…
Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella
Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Hen…
Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella
Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Hen…
DUBLIN–(BUSINESS WIRE)–The “Atrial Fibrillation – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This “Atrial Fibrillation – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ compan…